| A brief synthesis of (−)-englerin A Z Li, M Nakashige, WJ Chain Journal of the American Chemical Society 133 (17), 6553-6556, 2011 | 143 | 2011 |
| Heterocyclic compounds as immunomodulators J Li, L Wu, W Yao US Patent App. 15/355,494, 2017 | 111 | 2017 |
| The cytotoxicity of (−)-lomaiviticin A arises from induction of double-strand breaks in DNA LC Colis, CM Woo, DC Hegan, Z Li, PM Glazer, SB Herzon Nature chemistry 6 (6), 504-510, 2014 | 94 | 2014 |
| Heterocyclic compounds as immunomodulators L Wu, B Shen, J Li, Z Li, K Liu, F Zhang, W Yao US Patent App. 15/296,234, 2017 | 90 | 2017 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent App. 15/587,466, 2017 | 88 | 2017 |
| Heterocyclic compounds as immunomodulators L Wu, J Li, W Yao US Patent 10,308,644, 2019 | 81 | 2019 |
| Heterocyclic compounds as immunomodulators L Wu, DQ Qian, L Lu, N Lajkiewicz, LC Konkol, Z Li, F Zhang, J Li, ... US Patent App. 15/851,280, 2018 | 81 | 2018 |
| Heterocyclic compounds as immunomodulators L Wu, N Lajkiewicz, C He, K Xiao, W Zhu, Z Li, S Mei, C Qi, LC Konkol, ... US Patent App. 15/850,985, 2018 | 79 | 2018 |
| Heterocyclic compounds as immunomodulators L Wu, J Li, W Yao US Patent 10,669,271, 2020 | 67 | 2020 |
| Heterocyclic compounds as immunomodulators L Wu, B Shen, J Li, Z Li, K Liu, F Zhang, W Yao US Patent App. 16/005,961, 2019 | 66 | 2019 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent App. 15/906,655, 2019 | 63 | 2019 |
| Heterocyclic compounds as immunomodulators L Wu, J Li, W Yao, C Qi, DQ Qian, F Zhang US Patent 10,800,768, 2020 | 60 | 2020 |
| Englerin A Selectively Induces Necrosis in Human Renal Cancer Cells FJ Sulzmaier, Z Li, ML Nakashige, DM Fash, WJ Chain, JW Ramos PloS one 7 (10), e48032, 2012 | 49 | 2012 |
| Englerins: A Comprehensive Review Z Wu, S Zhao, DM Fash, Z Li, WJ Chain, JA Beutler Journal of Natural Products 80 (3), 771-781, 2017 | 47 | 2017 |
| Development of Enantioselective Synthetic Routes to (−)-Kinamycin F and (−)-Lomaiviticin Aglycon CM Woo, SL Gholap, L Lu, M Kaneko, Z Li, PC Ravikumar, SB Herzon Journal of the American Chemical Society 134 (41), 17262-17273, 2012 | 47 | 2012 |
| Total synthesis of plakortide e and biomimetic synthesis of plakortone b XY Sun, XY Tian, ZW Li, XS Peng, HNC Wong Chemistry-A European Journal 17 (21), 5874-5880, 2011 | 43 | 2011 |
| Heterocyclic compounds as LSD1 inhibitors C He, Z Li, L Wu, W Yao, F Zhang US Patent 9,944,647, 2018 | 37 | 2018 |
| Substituted imidazo [1, 2-a] pyrazines as LSD1 inhibitors L Wu, JR Courter, C He, J Li, L Lu, Y Sun, X Wang, W Yao, C Zhang, ... US Patent 9,695,180, 2017 | 34 | 2017 |
| Total synthesis of (±)-pallambins C and D XS Xu, ZW Li, YJ Zhang, XS Peng, HNC Wong Chemical Communications 48 (68), 8517-8519, 2012 | 34 | 2012 |
| Structural basis for DNA cleavage by the potent antiproliferative agent (–)-lomaiviticin A CM Woo, Z Li, EK Paulson, SB Herzon Proceedings of the National Academy of Sciences 113 (11), 2851-2856, 2016 | 30 | 2016 |
